BugSeq

BugSeq leads clinical bioinformatics in consortium (@Ginkgo, @JumpcodeG , @planetinnovate , @TGenResearch , and more) developing end-to-end metagenomic solution for @EU_HaDEA. See our announcement here: bugseq.com/news/2025/02/2…

We’re proud to team up with @GenomeBC on a new initiative to advance #Genomics in the fight against antimicrobial resistance! From scaling our #BugAMR platform to refining tools for rapid pathogen detection, we’re focused on one goal: faster, life-saving insights for healthcare.

Fantastic demonstration by the @AdventHealth team of the power of BugSeq in clinical practice: “Rapid and Routinely 24-Hour Antimicrobial Resistance Report for Mycobacterium abscessus Group by Whole-Genome Sequencing: A Tool for Appropriate Antimicrobial Therapy” 👇

Join BugSeq at ASM Microbe to see innovation in action! See the full BugSeq schedule, including demonstrations from our users: bugseq.com/resources/conf…

Check out recent updates to the BugSeq platform in our latest blog post: Advancing Viral Surveillance, Sequencing Flexibility, AMR Prediction, and EPI2ME Integration docs.bugseq.com/blog/2026/05/0…

Discover how public health laboratories are integrating BugSeq into their everyday bioinformatics routines! Visit us at booth 200 at @APHL 2026; we are eager to learn about the challenges you face and discuss how our solutions can support your work. #APHL

At #PASCV2026 ? Drop by the BugSeq booth (02T) to see how the most innovative labs are leveraging NGS to track viral outbreaks, antiviral resistance and more (and don’t forget to grab a notebook or bag)!

⏰ 16:15-17:15 CEST 📍 #Bioinformatics Pipeline Corner, Arena 4 🗣️ Sam Chorlton, BugSeq CEO See how we leverage interpretable AI to aid clinical translation and deliver industry-leading accuracy in: 🦠 Pathogen ID 💊 AMR prediction 📈 Outbreak analysis #ESCMIDGlobal2026

At #ESCMIDGlobal2026? Come visit booth H11 to learn more about how BugSeq can power your infectious disease bioinformatic workflows! From pathogen identification to AMR and outbreak analysis, BugSeq has a suite of analysis tools to power your NGS workflows.

Interested in learning more about leveraging BugSeq’s suite of infectious disease bioinformatic workflows with your @nanopore sequence data? Check out the ONT Booth at #ESCMIDGlobal2026 for a live demonstration and more details (full schedule below): #Booth-presentation-schedule" target="_blank" rel="nofollow noopener">nanoporetech.com/about/events/c…

Did you know you can now submit data to BugSeq directly through the @nanopore EPI2ME platform? Submitting ONT sequence data to BugSeq is now easier than ever! Check out the blog post for more details on the integration between ONT and BugSeq: epi2me.nanoporetech.com/epi2me-26.04-0…

The power of a curated database: BugSeq was most accurate for species identification in an independent evaluation of cloud-based platforms for microbial whole genome sequencing analysis. Read more: doi.org/10.1017/ash.20…

Miss the recent publication (doi.org/10.1128/jcm.01…) from @HopkinsMedicine leveraging BugSeq for infection control of C. auris? Stop by our booth at #SHEASpring2026 to learn how BugSeq powers genomic infection control programs.

This program is supported by @GenomeCanada and @GenomeBC through the Genomic Applications Partnership Program. Learn more about the program in the announcement.

Through this effort, the team will validate BugSeq’s bioinformatic platform to improve patient outcomes and strengthen Canadian biosecurity and pandemic preparedness.

BugSeq is delighted to partner with @UBC to improve detection, surveillance and early identification of emerging respiratory pathogens across Canada.

Hypervirulent Klebsiella pneumoniae is an emerging concern in clinical microbiology. Read how BugSeq was used to characterize the first cases of hypervirulent K. pneumoniae in Nebraska: doi.org/10.1128/asmcr.…

In case you missed it, the recording of the BugSeq + @nanopore webinar is now available on demand! Discover how Dr. Georgios Kitsios used BugSeq for respiratory metagenomics in the @UPMC ICU: nanoporetech.com/resource-centr…

→ docs.bugseq.com/blog/2026/01/0…

Clinical interpretation and reporting of next-generation sequencing assays is challenging. Check out our recent blog post to learn about how BugSeq leverages machine learning and configurable thresholds to implement evidence-based reporting for your NGS assay.🧬